NCT06944743 TURP Inpatient With Underactive Bladder With BOO
| NCT ID | NCT06944743 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | TURP Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is for aproved that Transurtheral Resection of prostate is good for patient with underactive bladder or not.
Eligibility Criteria
Inclusion Criteria: * Male patients diagnosed with BOO and UAB * Age ≥ 40 years. Exclusion Criteria: * Patient insulin dependent diabetes * Patient with history of cerbrovascular stroke or hemarrage. * History of prior prostate surgery. * Urethral pathology or surgery. * Patient with prostate or bladder cancer. * Spinal and pelvic trauma or surgery.
Contact & Investigator
Emad Mostafa, MD
PRINCIPAL INVESTIGATOR
Assistant lecture
Frequently Asked Questions
Who can join the NCT06944743 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 70 Years, studying TURP Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06944743 currently recruiting?
Yes, NCT06944743 is actively recruiting participants. Contact the research team at emad_mostafa@med.sohag.edu.eg for enrollment information.
Where is the NCT06944743 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06944743 clinical trial?
NCT06944743 is sponsored by Sohag University. The principal investigator is Emad Mostafa, MD at Assistant lecture. The trial plans to enroll 50 participants.